单位：[1]China Med Univ, Affiliate Hosp 4, Shenyang, Peoples R China[2]China Japan Friendship Hosp, Beijing, Peoples R China[3]Jilin Univ, Affiliate Hosp 2, Shenyang, Peoples R China[4]PLA, Acad Mil Med Sci, Inst 11, Changchun, Peoples R China[5]Chinese Peoples Liberat Army 65133rd Force, Dept Polit, Shenyang, Peoples R China[6]Minist Hlth, Chinese Peoples Liberat Army Shenyang Mil Reg Joi, Shenyang, Peoples R China[7]Shenyang Yucai Sch, Shenyang, Peoples R China[8]Wujing Gen Hosp Shenyang China, Shenyang, Peoples R China[9]95K China Med Univ, Shenyang, Peoples R China
BACKGROUND: Osteosarcoma is an aggressive cancerous neoplasm arising from primitive transformed cells of mesenchymal origin that exhibit osteoblastic differentiation and produce malignant osteoid. With the rapid development of tumor molecular biology, gene and viral therapy, a highly promising strategy for the treatment, has shown some therapeutic effects. OBJECTIVES: To study the strategy of cooperative cancer gene therapy, previously, we explored the antitumor effects of recombinant Fowl-pox viruses (FPVs) with both HN (hemagglutinin-neuramidinase) and VP3 genes on mouse osteosarcoma. MATERIALS AND METHODS: We constructed vFV-HN, vFV-VP3 and vFV-HN-VP3 inserting CAV VP3 gene, NDV HN gene into fowlpox virus. S180 osteosarcoma were transfected with Recombinant Fowl-pox viruses (FPVs). These cell lines stably expressing tagged proteins were selected by culturing in medium containing puromycin (2 mu g/ml) and confirmed by immunoblotting and immunostaining. S180 osteosarcoma model with BALB/c mice and nude mice were established and the vFPV viruses as control, vFV-HN, vFV-VP3, vFV-HN-VP3 were injected into the tumor directly. The rate of tumor growth, tumor suppression and the sialic acid levels in serum were examined and the tumor tissues were analyzed by the method of immunohistochemistry. Flow cytometric analysis was performed using a FAC-SCalibur flow cytometer. A total of 100,000 events were analyzed for each sample and the experiment was repeated at least twice. RESULTS: Our data indicated that vFV-HN, vFV-VP3 and vFV-HN-VP3 all had growth inhibition effects, the inhibition rate of vFV-HN-VP3 group was 51.7%, which was higher than that of vFV-HN, vFV-VP3 group and control group (p < 0.01). The sialic acid level of vFV-HN-VP3 group in mouse serum was 4.22 +/- 0.27 mmol/l, which was lower than that of other groups (p < 0.01). CONCLUSIONS: These results suggest that genes into mouse osteosarcoma cancer cells can cause cell a specificity anti-tumor immune activity, suppress tumor growth, and increase the survival rate of the tumor within host.
第一作者单位：[1]China Med Univ, Affiliate Hosp 4, Shenyang, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Z-Y.,Wang L-Q.,Fu C-F.,et al.Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma[J].EUROPEAN REVIEW for MEDICAL and PHARMACOLOGICAL SCIENCES.2013,17(6):767-776.
APA：
Zhang, Z-Y.,Wang, L-Q.,Fu, C-F.,Li, X.,Cui, Z-L....&Xu, F..(2013).Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma.EUROPEAN REVIEW for MEDICAL and PHARMACOLOGICAL SCIENCES,17,(6)
MLA：
Zhang, Z-Y.,et al."Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma".EUROPEAN REVIEW for MEDICAL and PHARMACOLOGICAL SCIENCES 17..6(2013):767-776
